Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Reduced GABA concentration in attention-deficit/hyperactivity disorder.

Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH.

Arch Gen Psychiatry. 2012 Jul;69(7):750-3. doi: 10.1001/archgenpsychiatry.2011.2280.

2.

Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders? Review.

de Cock M, Maas YG, van de Bor M.

Acta Paediatr. 2012 Aug;101(8):811-8. doi: 10.1111/j.1651-2227.2012.02693.x. Epub 2012 May 7. Review.

PMID:
22458970
3.

[Attention-deficit hyperactivity disorder: determination of the optimal medical treatment duration].

Zavadenko NN, Suvorinova NIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):28-32. Russian.

PMID:
22500309
4.
5.

Neuroimaging of tic disorders with co-existing attention-deficit/hyperactivity disorder.

Plessen KJ, Royal JM, Peterson BS.

Eur Child Adolesc Psychiatry. 2007 Jun;16 Suppl 1:60-70. Erratum in: Eur Child Adolesc Psychiatry. 2007 Dec;16(8):537.

6.

Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.

Saxena K, Howe M, Simeonova D, Steiner H, Chang K.

J Child Adolesc Psychopharmacol. 2006 Jun;16(3):252-9.

PMID:
16768633
7.

Favorable response of ADHD with giant SEP to extended-release valproate.

Miyazaki M, Ito H, Saijo T, Mori K, Kagami S, Kuroda Y.

Brain Dev. 2006 Aug;28(7):470-2. Epub 2006 Mar 22.

PMID:
16554135
8.

Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder.

Sparkes SJ, MacMaster FP, Carrey NC.

Brain Cogn. 2004 Mar;54(2):173-5. No abstract available.

PMID:
15025062
9.

Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.

Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, Schmidt M.

Clin Neuropharmacol. 2003 Jul-Aug;26(4):218-21.

PMID:
12897644
10.

Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder.

MacMaster FP, Carrey N, Sparkes S, Kusumakar V.

Biol Psychiatry. 2003 Jan 15;53(2):184-7.

PMID:
12547476
11.

Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism.

Dhossche D, Applegate H, Abraham A, Maertens P, Bland L, Bencsath A, Martinez J.

Med Sci Monit. 2002 Aug;8(8):PR1-6.

PMID:
12165753
12.
13.

Tics in Tourette syndrome: new treatment options.

Awaad Y.

J Child Neurol. 1999 May;14(5):316-9.

PMID:
10342599
14.

Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.

Mikati MA, Choueri R, Khurana DS, Riviello J, Helmers S, Holmes G.

J Intellect Disabil Res. 1998 Dec;42 Suppl 1:57-62.

PMID:
10030434
15.

Behavioral side effects of gabapentin in children.

Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA.

Epilepsia. 1996 Jan;37(1):87-90.

PMID:
8603631
16.

Behavioral deficits in rats with minimal cortical hypoplasia induced by methylazoxymethanol acetate.

Mercugliano M, Hyman SL, Batshaw ML.

Pediatrics. 1990 Mar;85(3 Pt 2):432-6.

PMID:
2304805
17.

[Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].

Lupandin VM, Lando LI, Gromova EA, Kamenskaia VM, Zykov MB.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1978;78(10):1538-44. Russian.

PMID:
716733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk